title: Quality of asthma care: results from a community pharmacy based survey.
abstract: BACKGROUND
  Optimal control is a major objective of disease management of asthma. The aim of the present study was to provide descriptive data on disease management in asthma patients, including medical resource utilization.
  
  
  METHODS
  Asthma patients (age 18-50 years) were consecutively recruited in 348 dispensing pharmacies. They completed a questionnaire which collected data on personal characteristics, asthma management, including medical resource utilization, including asthma management. Asthma control was measured with the Asthma Control Test. Data from computerized pharmacy records of medications, dispensed before inclusion, were also collected.
  
  
  RESULTS
  In 1791 eligible patients, 1559 accepted to participate in the study (mean age = 36.5, 56.1% of females). During the previous 4 weeks, the asthma control was satisfactory for only 28% of the patients, despite extensive provision of anti-inflammatory asthma control treatments (89%). Combinations of long acting beta agonists (LABA) and inhaled corticosteroids (ICS) were commonly used (59%), while fewer patients received LABA and ICS as two separate medications (15%). In addition, short-acting beta agonists, were frequently dispensed (71%). A substantial number of patients consulted their GPs on a monthly basis. Patients commonly reported daily shortness of breath (30%), daily use of rescue medication (29%) and weekly nocturnal symptoms (32%). Surprisingly, most patients considered their asthma as completely or well controlled (76%).
  
  
  CONCLUSIONS
  Our results clearly identify a need to improve the management of asthma. Education programmes would be beneficial to improve asthma control.
authors.affiliation: Pharmacoepidemiology Unit, CHU-Lyon, France.
authors.forename: L
authors.initials: L
authors.lastname: Laforest
authors.forename: E
authors.initials: E
authors.lastname: Van Ganse
authors.forename: G
authors.initials: G
authors.lastname: Devouassoux
authors.forename: S
authors.initials: S
authors.lastname: Chretin
authors.forename: G
authors.initials: G
authors.lastname: Bauguil
authors.forename: Y
authors.initials: Y
authors.lastname: Pacheco
authors.forename: G
authors.initials: G
authors.lastname: Chamba
mesh_terms: D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology* / Q000517:prevention & control; D003695:Delivery of Health Care / Q000706:statistics & numerical data; D005260:Female; D005602:France / Q000453:epidemiology; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D010594:Pharmacies; D011795:Surveys and Questionnaires
chemical_list: D018927:Anti-Asthmatic Agents